logo
Select company
Select metric
$ -1.65MShareholders Equity
VS
Market
11
Sector
13
Industry
14
History
15
$ 4.01Close
$ 1.67 - $ 9.13 52-Week Range
Ticker Information

Ticker

QLGN

Company Name

QUALIGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

QUALIGEN THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

QLGN - Equity Historical data
DateShareholders Equity
6/30/2025$ -1.65M
3/31/2025$ 33.13K
12/31/2024$ 2.68M
9/30/2024$ -2.14M
6/30/2024$ -4.28M
3/31/2024$ -3.52M
12/31/2023$ -2.1M
9/30/2023$ -1.64M
6/30/2023$ 2.03M
3/31/2023$ 4.87M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

QLGN - Shareholders Equity, Last 5 years

$ -4.28M

Minimum

Jun 30, 2024

$ 18.29M

Maximum

Dec 31, 2020

$ 5.65M

Average

$ 3.77M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 385.07M with a standard deviation of $ 549.23M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 385.07M
median$ 167.44M
std$ 549.23M